Cowen Prime Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-800
| Closed | -$322K | – | 220 |
|
|
2016
Q3 | $322K | Buy |
+800
| New | +$322K | 0.15% | 85 |
|
|
2015
Q4 | – | Sell |
-600
| Closed | -$279K | – | 249 |
|
|
2015
Q3 | $279K | Buy |
600
+500
| +500% | +$233K | 0.13% | 85 |
|
|
2015
Q2 | $51K | Sell |
100
-900
| -90% | -$459K | 0.02% | 159 |
|
|
2015
Q1 | $451K | Buy |
1,000
+500
| +100% | +$226K | 0.19% | 75 |
|
|
2014
Q4 | $205K | Hold |
500
| – | – | 0.08% | 115 |
|
|
2014
Q3 | $180K | Buy |
+500
| New | +$180K | 0.08% | 111 |
|
|
2014
Q2 | – | Sell |
-1,000
| Closed | -$300K | – | 286 |
|
|
2014
Q1 | $300K | Hold |
1,000
| – | – | 0.11% | 75 |
|
|
2013
Q4 | $275K | Hold |
1,000
| – | – | 0.11% | 85 |
|
|
2013
Q3 | $313K | Hold |
1,000
| – | – | 0.12% | 87 |
|
|
2013
Q2 | $230K | Buy |
+1,000
| New | +$230K | 0.1% | 101 |
|